These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19823032)

  • 21. IgG Responses to the Plasmodium falciparum Antigen VAR2CSA in Colombia Are Restricted to Pregnancy and Are Not Induced by Exposure to Plasmodium vivax.
    Lopez-Perez M; Larsen MD; Bayarri-Olmos R; Ampomah P; Stevenson L; Arévalo-Herrera M; Herrera S; Hviid L
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29784859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens.
    Nielsen MA; Vestergaard LS; Lusingu J; Kurtzhals JA; Giha HA; Grevstad B; Goka BQ; Lemnge MM; Jensen JB; Akanmori BD; Theander TG; Staalsoe T; Hviid L
    Infect Immun; 2004 Jun; 72(6):3531-5. PubMed ID: 15155661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy.
    Feng G; Aitken E; Yosaatmadja F; Kalilani L; Meshnick SR; Jaworowski A; Simpson JA; Rogerson SJ
    J Infect Dis; 2009 Jul; 200(2):299-306. PubMed ID: 19500037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The promise of asexual malaria vaccine development.
    Pasloske BL; Howard RJ
    Am J Trop Med Hyg; 1994; 50(4 Suppl):3-10. PubMed ID: 8172329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Plasmodium falciparum malaria vaccines: evidence-based searching for variant surface antigens as candidates for vaccination against pregnancy-associated malaria.
    Staalsoe T; Jensen AT; Theander TG; Hviid L
    Immunol Lett; 2002 Nov; 84(2):133-6. PubMed ID: 12270550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro Variant Surface Antigen Expression in Plasmodium falciparum Parasites from a Semi-Immune Individual Is Not Correlated with Var Gene Transcription.
    Bruske EI; Dimonte S; Enderes C; Tschan S; Flötenmeyer M; Koch I; Berger J; Kremsner P; Frank M
    PLoS One; 2016; 11(12):e0166135. PubMed ID: 27907004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection.
    Mount AM; Mwapasa V; Elliott SR; Beeson JG; Tadesse E; Lema VM; Molyneux ME; Meshnick SR; Rogerson SJ
    Lancet; 2004 Jun; 363(9424):1860-7. PubMed ID: 15183624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of naturally acquired immunity to P. falciparum and approaches to identify merozoite antigen targets.
    Healer J; Chiu CY; Hansen DS
    Parasitology; 2018 Jun; 145(7):839-847. PubMed ID: 29144217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Of mice and women: rodent models of placental malaria.
    Hviid L; Marinho CR; Staalsoe T; Penha-Gonçalves C
    Trends Parasitol; 2010 Aug; 26(8):412-9. PubMed ID: 20605743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
    Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.
    Hommel M; Chan JA; Umbers AJ; Langer C; Rogerson SJ; Smith JD; Beeson JG
    Parasit Vectors; 2018 Jan; 11(1):69. PubMed ID: 29378634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
    Nielsen MA; Resende M; de Jongh WA; Ditlev SB; Mordmüller B; Houard S; Ndam NT; Agerbæk MØ; Hamborg M; Massougbodji A; Issifou S; Strøbæk A; Poulsen L; Leroy O; Kremsner PG; Chippaux JP; Luty AJ; Deloron P; Theander TG; Dyring C; Salanti A
    PLoS One; 2015; 10(9):e0135406. PubMed ID: 26327283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical development of a VAR2CSA-based placental malaria vaccine PAMVAC: Quantifying vaccine antigen-specific memory B & T cell activity in Beninese primigravidae.
    Gbédandé K; Fievet N; Viwami F; Ezinmegnon S; Issifou S; Chippaux JP; Dossou Y; Moutairou K; Massougbodji A; Ndam N; de Jongh WA; Søgaard TMM; Salanti A; Nielsen MA; Esen M; Mordmüller B; Deloron P; Luty AJF;
    Vaccine; 2017 Jun; 35(27):3474-3481. PubMed ID: 28527688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.
    Makobongo MO; Keegan B; Long CA; Miller LH
    J Infect Dis; 2006 Mar; 193(5):731-40. PubMed ID: 16453270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
    de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
    Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria vaccines.
    Romero P
    Curr Opin Immunol; 1992 Aug; 4(4):432-41. PubMed ID: 1388845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The immunological aspects of tropical malaria related to the development of an antimalarial vaccine].
    Chirkov VP; Popov AF
    Med Parazitol (Mosk); 2000; (2):56-8. PubMed ID: 10900926
    [No Abstract]   [Full Text] [Related]  

  • 39. Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants.
    Tessema SK; Nakajima R; Jasinskas A; Monk SL; Lekieffre L; Lin E; Kiniboro B; Proietti C; Siba P; Felgner PL; Doolan DL; Mueller I; Barry AE
    Cell Host Microbe; 2019 Nov; 26(5):579-590.e5. PubMed ID: 31726028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults.
    Elliott SR; Payne PD; Duffy MF; Byrne TJ; Tham WH; Rogerson SJ; Brown GV; Eisen DP
    Am J Trop Med Hyg; 2007 May; 76(5):860-4. PubMed ID: 17488905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.